相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Bela Horvath et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
Monica Alonso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The L-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
Jose Maria Moreno-Navarrete et al.
DIABETES (2012)
The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats
A. Diaz-Arteaga et al.
DIABETES OBESITY & METABOLISM (2012)
Cannabinoids Induce Pancreatic β-Cell Death by Directly Inhibiting Insulin Receptor Activation
Wook Kim et al.
SCIENCE SIGNALING (2012)
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
D. Vara et al.
CELL DEATH AND DIFFERENTIATION (2011)
Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
C. Li et al.
DIABETES OBESITY & METABOLISM (2011)
Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice
M. Bajzer et al.
DIABETOLOGIA (2011)
CNS Opioid Signaling Separates Cannabinoid Receptor 1-Mediated Effects on Body Weight and Mood-Related Behavior in Mice
Sarah Haas Lockie et al.
ENDOCRINOLOGY (2011)
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice
K. S. Bell-Anderson et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes
Dipanjan Chanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance
Ulrike Taschler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
Silvana Y. Romero-Zerbo et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
Ravi Murumalla et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects
Sebastiano Banni et al.
NUTRITION & METABOLISM (2011)
Acute Overactive Endocannabinoid Signaling Induces Glucose Intolerance, Hepatic Steatosis, and Novel Cannabinoid Receptor 1 Responsive Genes
Maxwell A. Ruby et al.
PLOS ONE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Rimonabant, a Cannabinoid Receptor Type 1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating Liver Kinase B1 and AMP-Activated Protein Kinase Axis Downstream of Gαi/o Inhibition
Hong Min Wu et al.
MOLECULAR PHARMACOLOGY (2011)
G1359A Polymorphism in the Cannabinoid Receptor-1 Gene Is Associated with Metabolic Syndrome in the Chinese Han Population
Wen-Chao Hu et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 beta-cells
Chen Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
被撤回的出版物: Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells (Retracted article. See vol. 70, pg. 1910, 2021)
Christopher Lipina et al.
DIABETES (2010)
Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver The Role of eNOS, p38 MAPK, and AMPK Pathways
Laura Tedesco et al.
DIABETES (2010)
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
K. A. Lindborg et al.
DIABETES OBESITY & METABOLISM (2010)
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
J. Agudo et al.
DIABETOLOGIA (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma
JodiAnne T. Wood et al.
JOURNAL OF LIPID RESEARCH (2010)
Modulation of Adipocyte Biology by Δ9-Tetrahydrocannabinol
Diana Teixeira et al.
OBESITY (2010)
Reversal of Inflammation-Induced Impairment of Glucose Uptake in Adipocytes by Direct Effect of CB1 Antagonism on Adipose Tissue Macrophages
Alexandra Miranville et al.
OBESITY (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial
Jean-Pierre Despres et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
Koichi Sugamura et al.
CIRCULATION (2009)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
K. Eckardt et al.
DIABETOLOGIA (2009)
Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716)
Aaron N. A. Verty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
Barbara Batetta et al.
JOURNAL OF NUTRITION (2009)
Metabolism of Anandamide by COX-2 Is Necessary for Endocannabinoid-Induced Cell Death in Tumorigenic Keratinocytes
Rukiyah T. Van Dross
MOLECULAR CARCINOGENESIS (2009)
Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation
Sevasti Karaliota et al.
OBESITY (2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux et al.
PLOS ONE (2009)
Targeting of PKCζ and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide
Eric Hajduch et al.
BIOCHEMICAL JOURNAL (2008)
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
K. L. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Temporal and Site-Specific Brain Alterations in CB1 Receptor Binding in High Fat Diet-Induced Obesity in C57Bl/6 Mice
T. South et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
The Cannabinoid CB1 Receptor Antagonist Rimonabant Stimulates 2-Deoxyglucose Uptake in Skeletal Muscle Cells by Regulating the Expression of Phosphatidylinositol-3-kinase
Iolanda Esposito et al.
MOLECULAR PHARMACOLOGY (2008)
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet
Katarzyna M. Starowicz et al.
OBESITY (2008)
Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors
Masanori Nakata et al.
REGULATORY PEPTIDES (2008)
Presence of functional cannabinoid receptors in human endocrine pancreas
F. J. Bermudez-Silva et al.
DIABETOLOGIA (2008)
Cannabinoids as therapeutic agents in cardiovascular disease:: a tale of passions and illusions
V. E. Mendizabal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
Andriam Athanasiou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The expression of receptors for endocannabinoids in human and rodent skeletal muscle
Paul Cavuoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Blockade of central cyclooxygenase (COX) pathways enhances the cannabinold-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception
Dong K. Ahn et al.
PAIN (2007)
Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity
K. Kempf et al.
HORMONE AND METABOLIC RESEARCH (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study
Tuba Esfandyari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity
Balapal S. Basavarajappa
CURRENT NEUROPHARMACOLOGY (2007)
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men
Armand Peeters et al.
ENDOCRINE (2007)
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
P. Cavuoto et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Identification of endocannabinoids and related compounds in human fat cells
Marie-Paule Gonthier et al.
OBESITY (2007)
The N-acylethanolamine-hydrolyzing acid amidase (NAAA)
Kazuhito Tsuboi et al.
CHEMISTRY & BIODIVERSITY (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
Kristin Gustafsson et al.
MOLECULAR PHARMACOLOGY (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
P Juan-Picó et al.
CELL CALCIUM (2006)
Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit
YH Jo et al.
NEURON (2005)
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
F Massa et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Identification of N-arachidonylglycine, U18666A, and 4-androstene-3,17-dione as novel insulin secretagogues
Y Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
JC Sipe et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
B Kola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
EL Gardner
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
YL Liu et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin
G Burdyga et al.
JOURNAL OF NEUROSCIENCE (2004)
The endogenous cannabinoid system and the treatment of marijuana dependence
D Piomelli
NEUROPHARMACOLOGY (2004)
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
M Bensaid et al.
MOLECULAR PHARMACOLOGY (2003)
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
MA Casu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors
PH Reggio
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
2-arachidonoylglycerol and the cannabinoid receptors
T Sugiura et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
分享论文
